Veradermics MANE Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Veradermics ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Veradermics 's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Veradermics 's net change in cash?
- Veradermics (MANE) reported net change in cash of $146.65M in Q1 2026.
- How has Veradermics 's net change in cash changed year-over-year?
- Veradermics 's net change in cash increased by 810.4% year-over-year, from -$20.64M to $146.65M.
- What does net change in cash mean?
- The total change in the company's cash balance over the period.
- How do you interpret net change in cash?
- An increase indicates a net inflow of cash, while a decrease indicates cash burn, which is critical for pre-revenue companies.
- How does net change in cash compare across companies?
- Standard metric reported by all companies; essential for assessing runway in clinical-stage firms.